GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for BPTI/KUNITZ inhibitor domain- containing protein C02F12.5 (Q11101)

Analyse AlphaFold monomer V2.0 prediction for BPTI/KUNITZ inhibitor domain- containing… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
Q11101
Type
protein
Length
176 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x7782F4817b37743d738e9aF842bf74bd50f2015E
Molecule
BPTI/KUNITZ inhibitor domain-containing protein C02F12.5
UniProt
Q11101
Pockets
1 · best druggability 0.47

Structure

1 distinct chain · 26% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABPTI/KUNITZ inhibitor domain-containing protein C02F12.5protein17626% helix, 28% strandQ11101

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11550.470.7728empty

Modifications

Observed in the structure: 9 disulfide (disulfide).

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.